Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02868008 : Multimodal Imaging Techniques in Assessing the Surgical Risk for Eloquent Arteriovenous Malformations
AgesMin: 12 Years Max: 60 Years
Inclusion Criteria:

1. Patients aged between 12 and 60 years

2. Data from preoperative structural MRI, blood oxygen level dependent (BOLD)-fMRI,
time-of-flight magnetic resonance angiography (TOF-MRA), and DTI of the motor
tract,language tract or optic radiation were available

3. Patients with a definite diagnosis of AVM confirmed by preoperative digital
subtraction angiography

4. Patients opting for surgical management at the five centers in this study

5. Patients without any interventional therapy (microsurgery, radiosurgery, endovascular
embolization, or multimodality treatment) before admission to the five centers

Exclusion Criteria:

1. Patients with acute intracranial hematoma and resultant brain hernia prompting
emergency surgery

2. Patients with a hemorrhagic incident in the past month

3. Nonavailability of BOLD-fMRI and DTI data

4. Patients with other severe diseases that prevented them from having surgery

5. Patients unwilling to participate in the trial
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557